One Biology
One Platform
Two Species
We develop inhaled immunotherapy against lung cancer and lung metastases, first in dogs with naturally occurring cancer with a program built to translate to human lung cancer.
Dogs develop cancer much as people do, spontaneously, with intact immune systems, sharing our homes and our environment. We believe treating them better can help us treat ourselves better. That is One Health.
Cancer is the #1 cause of death in dogs & cats, but still veterinary medicine is decades behind human medicine. Pet owners want better therapies for their four-legged family member.
Immuvera Therapeutics is a Norwegian biotech company developing inhaled immunotherapy for cancer in dogs and humans. Our team combines veterinary oncology, human drug development and regulatory science.
Four Decades
Of Veterinary and Human Oncology experience
Four Patent Families
First granted
Two Species
One platform for veterinary and human medicine
"Seeing how our innovative immunotherapy protocols are giving hope to pet owners facing cancer diagnoses is what drives our work. We're bridging the gap between human and veterinary oncology for better outcomes."
Dr. Lars Moe
Chief Medical Officer
